BUPRENORPHINE 2,2'-DIMER
UNII 43MH6YYF5W

Substance Identification & Data

This profile provides standardized clinical and technical data for Buprenorphine 2,2'-dimer, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 43MH6YYF5W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 163597-04-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

43MH6YYF5W

CAS Registry Number

163597-04-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BUPRENORPHINE 2,2'-DIMER

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C58H80N2O8

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IIKJUPFUFVJKHV-XXSTYBPCSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

139468475

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1C[C@@]2([C@]3([C@]45c6c(c(c(cc6C[C@]([C@@]41C[C@@]2([C@](C(C)(C)C)(C)O)[H])(N(CC7CC7)CC5)[H])-c8c(c9c%10c(c8)C[C@@]%11([C@]%12%13[C@@]%10([C@]([C@]([C@](C%12)([C@](C(C)(C)C)(C)O)[H])(CC%13)OC)(O9)[H])CCN%11CC%14CC%14)[H])O)O)O3)[H])OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Buprenorphine 2,2'-dimer. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

6.ALPHA.,14-ETHANO-14.ALPHA.-MORPHINAN

BUPRENORPHINE 2,2'-DIMER

BUPRENORPHINE HYDROCHLORIDE IMPURITY G [EP IMPURITY]

BUPRENORPHINE IMPURITY G [EP IMPURITY]

PSEUDOBUPRENORPHINE

Systematic Nomenclature

(.ALPHA.S,5.ALPHA.,7.ALPHA.)-(.ALPHA.'S,5'.ALPHA.,7'.ALPHA.)-17,17'-BIS(CYCLOPROPYLMETHYL)-.ALPHA.,.ALPHA.'-BIS(1,1-DIMETHYLETHYL)-4,5:4',5'-DIEPOXY-18,18',19,19'-TETRAHYDRO-3,3'-DIHYDROXY-6,6'-DIMETHOXY-.ALPHA.,.ALPHA.'-DIMETHYL(2,2'-BI-6,14-ETHENOMORPHINAN)-7,7'-DIMETHANOL

SYS

(2,2'-BI-6,14-ETHENOMORPHINAN)-7,7'-DIMETHANOL, 17,17'-BIS(CYCLOPROPYLMETHYL)-.ALPHA.,.ALPHA.'-BIS(1,1-DIMETHYLETHYL)-4,5:4',5'-DIEPOXY-18,18',19,19'-TETRAHYDRO-3,3'-DIHYDROXY-6,6'-DIMETHOXY-.ALPHA.,.ALPHA.'-DIMETHYL-, (5.ALPHA.,7.ALPHA.(S))-(5'.ALPHA.,7'.ALPHA.(S))-

SYS

17,17'-DI(CYCLOPROPYLMETHYL)-4,5.ALPHA.;4',5.ALPHA.'-DIEPOXY-7.ALPHA.,7.ALPHA.'-DI((1S)-1-HYDROXY-1,2,2-TRIMETHYLPROPYL)-6,6'-DIMETHOXY-2,2'-BI

SYS

2,2'-BI(17-(CYCLOPROPYLMETHYL)-4,5.ALPHA.-EPOXY-3-HYDROXY-7.ALPHA.-((S)-2-HYDROXY-3,3-DIMETHYLBUTAN-2-YL)-6-METHOXY-6.ALPHA.,14-ETHANOMORPHINAN)

SYS